Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features

OBJECTIVE: The use of a neoadjuvant chemoradiation followed by surgery in patients with stage IIIA NSCLC is controversial and the benefit of surgery is limited. There are currently no clinically validated biomarkers to select patients for such an approach. In this study we evaluate computed tomograp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lung Cancer
Egile Nagusiak: Khorrami, Mohammadhadi, Jain, Prantesh, Bera, Kaustav, Patil, Pradnya, Ahmad, Usman, Murthy, Sudish, Stephans, Kevin, Fu, Pingfu, Velcheti, Vamsidhar, Madabhushi, Anant
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711393/
https://ncbi.nlm.nih.gov/pubmed/31446979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2019.06.020
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak